Quantcast

Latest Viral structural proteins Stories

2014-04-14 11:03:19

Three new studies presented today at the International Liver CongressTM 2014 have helped clarify the optimal use of combination therapy with peginterferon and nucleoside analogues (NUCs) to achieve the best treatment outcomes in patients with chronic hepatitis B (CHB). "Together these ground-breaking data will go a long way to influencing future CHB treatment guidelines," said EASL's Educational Councillor Professor Cihan Yurdaydin from the Department of Gastroenterology, University of...

2012-04-19 19:55:06

Additional data provides hope for HCV non-responders New data from a number of clinical trials presented for the first time at the International Liver Congress 2012 provides hope for previously difficult to treat hepatitis C (HCV) patient populations. In the first multicentric study of the efficacy and safety of the protease inhibitors (PI) Boceprevir or Telaprevir in patients with severe HCV genotype 1 (GT1) recurrence after liver transplantation, results show that 57% of patients...

2011-07-28 10:32:00

New tool to help identify areas for increased education and screening for hepatitis C WASHINGTON, July 28, 2011 /PRNewswire-USNewswire/ -- In recognition of World Hepatitis Day, the National Minority Quality Forum today launched the Hepatitis C Index, a novel resource for mapping hepatitis C (http://www.maphepc.com). For the first time, health-care practitioners, policy makers, advocacy groups, and researchers will be able to quantify and map hepatitis C (HCV) prevalence and total...

2011-06-23 15:31:21

NewYork-Presbyterian/Weill Cornell physician-scientist leads study reporting that FDA-approved telaprevir-based regimen acts faster and offers a stronger viral cure than standard treatment The drug telaprevir (Incivek) provides a dramatic improvement in the treatment of the most common form of hepatitis C infection, says an international team of investigators led by Dr. Ira M. Jacobson of NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Their study, published in today's edition of...

fb6faacc9de1209e6520ae547da949c31
2011-02-14 10:35:00

Researchers study flu proteins in-depth to identify virus vulnerabilities Each year, people everywhere prepare for flu season. Some will get the flu vaccine, some take vitamin supplements, some launch a vigorous handwashing campaign, while others take an entirely different approach: nuclear magnetic resonance (NMR). Mei Hong, a chemist at Iowa State University, uses NMR to study a proton channel named M2, found on the surface of the influenza virus. This proton channel has been the subject of...

2010-11-01 08:35:00

BOSTON, Nov. 1, 2010 /PRNewswire/ -- Researchers studied the treatment of pregnant women with hepatitis B virus (HBV) with Telbivudine in their second to third trimesters. The study concluded that both the mothers benefited from treatment and no transmission of HBV to newborns was detected at 28 weeks postbirth. The study presenter and co-investigator Calvin Pan, MD, anticipates a "very powerful impact in the field, as hepatitis B is difficult to eradicate and currently there is no...

2010-03-02 08:30:00

WATERTOWN, Mass., March 2 /PRNewswire/ -- Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing. "Our NS5A inhibitor program is well positioned to generate a pipeline of clinical candidates, and we are excited about further...

2010-02-10 09:10:21

Hepatitis B virus (HBV) genotypes have distinct geographical distributions, and have been shown to differ with regard to clinical outcome and prognosis. However, the relationship between HBV genotypes and liver cirrhosis remains controversial and no study on exploring the association between HBV genotypes and subclinical cirrhosis in community-based population has been reported. A research article to be published on January 21, 2010 in the World Journal of Gastroenterology addresses this...

2009-12-15 20:43:52

Research published this week in PLoS Medicine finds that the global spread of Hepatitis C virus (HCV) coincided with widespread use of transfused blood and with the expansion of intravenous drug use but slowed before wholesale implementation of anti-HCV screening. Angelos Hatzakis and colleagues used phylodynamic and phylogeographic methods to analyse sequences of HCV subtype 1a and 1b samples (these subtypes cause 60% of global HCV infections) collected over the past 20-30 years in the Los...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.